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Executive Summary
In many countries in sub-Saharan Africa, HIV programs are organized around pediatric or adult care,
with adolescents who are living with HIV being treated through pediatric care facilities. This has
important implications for retention of adolescents in HIV care programs especially as they transition
from pediatric to adult care. Although Uganda is considered a success story in HIV/AIDS programming,
the extent to which adolescents living with HIV have been retained in care is not well understood.
Retention in care is important for positive clinical outcomes such as viral load suppression and survival.
The AIDS Support Organization (TASO) and the Population Council undertook a study to generate
evidence on the level of and the factors associated with retention of adolescents aged 10–19 years in
HIV and AIDS programs in Uganda. The study was conducted under the U.S. Agency for International
Development’s (USAID) HIVCore project led by the Population Council. The study specifically
examined: (1) the contextual factors that might facilitate or influence retention of adolescents in HIV
care, treatment, and support services in Uganda; (2) the cascade of HIV care, treatment, and support
services among adolescents aged 10–19 years in Uganda and how these patterns compare with those of
adults aged 20 years and above; (3) the level of and trends in retention in care, treatment, and support
programs among adolescents aged 10–19 years in the country in the context of current HIV and AIDS
programs at 6, 12, 24, 36, and 48 months following initiation of antiretroviral therapy (ART); and (4) the
sociodemographic characteristics that are associated with retention in HIV care, treatment, and support
programs among adolescents in Uganda at three different follow-up periods (12, 24, and 36 months).
The study reviewed existing national policy and program documents on HIV testing, counseling,
treatment, and support as well as retrospective secondary cohort clinical data from clinics operated by
TASO in Uganda. TASO implements several HIV-related activities including prevention, counseling,
testing, treatment, care, and support services as well as capacity development, research, and advocacy. The
study population for the clinical component comprised: (1) 22,089 adolescents aged 10–19 years and
33,139 adults aged 20 years and above who received HIV services under the home-based HIV testing
and counseling (HBHTC) program from 2005 (when TASO initiated the program) to 2011; and (2)
clinical records of 617 adolescent clients aged 10–19 years (at the time of enrollment) who received
HIV care, treatment, and support services from TASO clinics between 2006 and 2011. The review of
policy and program documents as well as the extraction and merging of clinical datasets took place
from 4–15 November 2013. The HBHTC and ART datasets were obtained from 11 TASO centers.
The ART datasets were extracted from the following records: Pre-ART Registry, Case Evaluation, ART
Commencement, Deaths, Monitoring Refills, and Laboratory. We identified a patient cohort within
the TASO Management Information System who initiated ART since 2006. Analysis involved both
descriptive statistics and multivariate Cox regression analysis. Descriptive analysis entailed reviewing the
cascade of HIV care, treatment, and support services under the HBHTC program as well as estimating
the level of retention in TASO ART programs at 6, 12, 24, 36, and 48 months. Multivariate Cox
regression analysis was conducted to determine the sociodemographic and clinical factors associated with
program attrition at 12, 24, and 36 months.
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Key Findings

yy The HBHTC program contributed to increasing proportions of adolescents aged 10–19 years being
enrolled in TASO care centers during the first four years of its operation. In particular, among the
adolescents who tested HIV positive in TASO’s HBHTC programs, the proportion that was enrolled
in TASO centers more than quadrupled from 9 percent in 2005 to 41 percent in 2008. However, that
proportion declined thereafter by about half to 20 percent by 2010.
yy The overall level of retention of adolescents in TASO ART programs was 96 percent at 6 months,
90 percent at 12 months, 83 percent at 24 months, 76 percent at 36 months, and 71 percent at 48
months, which is comparable with those of adults in existing studies. However, there were variations in
the level of retention of various cohorts of adolescents especially from 12 months onwards. Specifically,
retention at each time period decreased among adolescents initiating ART in each successive year
after 2006 and the gaps widened with longer duration of observation. The high levels of retention of
adolescents in TASO treatment programs could, however, be due to the intensive resources geared
towards targeting whole families with HIV testing, counseling, treatment, and support services. Thus,
although resources for targeting whole families may not always be available, the programs provide
valuable lessons for improving access to treatment services for HIV-positive adolescents.
yy The risk of non-retention of adolescents in TASO programs was significantly greater among those who
obtained their antiretroviral (ARV) drug refills from a health facility than among those who obtained
the refills from community drug distribution points at all the time points considered (12, 24, and 36
months). In addition, the risk of non-retention in care was significantly greater among adolescents at
WHO clinical stage 3 and 4 than among those at stage 1 and 2 at 12 months. The findings suggest that
community-based ART distribution initiatives and early diagnosis of HIV infection do improve the
chances of retaining adolescents in ART programs. Variations in the risk of non-retention in treatment
programs by venue of drug refills could be due to most adolescents receiving drugs from community
drug distribution points being those with high levels of adherence. A cross-tabulation of adherence
level and venue of drug refill though, showed that there was no significant association between the two
attributes, suggesting that counseling and close monitoring might have improved adherence among
clients who received drug refills from facilities.
yy The risk of non-retention in care was significantly greater among older (15–19 years) than among
younger (10–14 years) adolescents at 12 and 24 months. In addition, at 24 and 36 months, the risk of
non-retention in care was significantly greater among adolescents with higher than among those with
lower CD4 count at the time of initiating ART.
yy Contrary to existing literature (Braitstein et al. 2008) which indicates that females are better at seeking
healthcare than males, the results of this study showed that with longer duration of observation (at 24
and 36 months), the risk of non-retention in care was significantly lower among male compared to
female adolescents.

Recommendations

yy HIV care, treatment, and support programs in Uganda should strengthen such strategies as community
drug distribution points, which have the potential to improve retention of adolescents in care and
treatment, to specifically target those who are at high risk of dropping out.
yy Further research is needed to determine whether setting up transition units to cater to older adolescents
who receive services from health facilities but are not comfortable with obtaining services from
pediatric or adult clinics could improve retention among adolescents.
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yy Further research involving collection of primary quantitative and qualitative data is needed to
determine why later cohorts of adolescents had lower levels of retention in care compared to earlier
cohorts and why male adolescents had significantly lower risk of non-retention in care compared to
their female counterparts.

Retention of Adolescents Living with HIV in Care, Treatment, and Support Programs in Uganda ■ 3

INTRODUCTION
Globally, the number of children aged under 15 years who were living with HIV increased from 2.0
million in 2001 to 2.5 million by the end of 2010 (UNAIDS 2010a). Most of these children (90
percent) were in sub-Saharan Africa, where the number increased from 1.8 million to 2.3 million
over the same period (UNAIDS 2010a). New infections and the expansion of antiretroviral treatment
(ART) contributed to the increased number of children living with HIV (UNAIDS 2011). In Uganda,
for instance, it was estimated that 190,000 children aged under 15 years were living with HIV as of
2011, while 21,000 new infections occurred among this age group in that year (UNAIDS 2012). The
implication is that increasing numbers of children infected with HIV in sub-Saharan Africa mature into
adolescence and adulthood. As with most adolescents, many of these young people become sexually active
and even have children (Birungi et al. 2008, 2011). Moreover, many adolescents who were not born with
HIV become sexually active and expose themselves to the risk of HIV infection by not or inconsistently
using preventive methods (Hindin and Fatusi 2009). In Uganda, for example, estimates show that HIV
prevalence among adolescents aged 15–19 years is 2.4 percent (3.0 percent and 1.7 percent among
adolescent girls and boys respectively) (Ministry of Health et al. 2012).
Yet, in many countries in sub-Saharan Africa, HIV programs are organized around pediatric or adult care
with adolescents who are living with HIV being treated through pediatric care facilities. Such facilities are
ill-equipped to provide adolescents with the information they need to deal with sexual and reproductive
health (SRH) issues of concern to them. For example, available evidence from Kenya and Uganda shows
that the majority of adolescents who are living with HIV are very worried about becoming pregnant or
impregnating someone, disclosing their HIV status, and infecting others and re-infecting themselves; yet
their preventive practices are just as poor as among adolescents in general (Birungi et al. 2008, 2011).
Moreover, existing counseling services for adolescents have not provided pragmatic solutions for those
who are sexually active beyond emphasizing that they should refrain from sexual activity, which in most
cases is not heeded (Birungi et al. 2008). Evidence from Uganda further shows that many adolescent girls
disappear from HIV and AIDS programs once they become pregnant and it is obvious that they did not
heed the counselors’ advice to refrain from sexual activity (Birungi et al. 2009).
The gaps in HIV and AIDS programming for adolescents living with HIV have important implications
for retention of this age group in HIV care, treatment, and support programs as well as for adherence to
treatment, especially as they transition from pediatric to adult clinics. For example, available evidence
indicates that in low-resource settings, adherence to treatment is generally poorer among adolescents
compared to children or adults (Foster and Fidler 2010). Moreover, although Uganda has been considered
a success story in HIV and AIDS programming that contributed to substantial declines in HIV prevalence
over time (Ministry of Health et al. 2012), there has been little consideration of the extent to which the
country has succeeded in retaining HIV-positive adolescents aged 10–19 years in such programs given the
challenges faced by this subset of the population regarding adherence as well as transition from pediatric
to adult care. This raises some important research questions:
1. What is the level of retention in HIV and AIDS programs among HIV-positive adolescents aged 10–19
years in the country?
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2. Are HIV-positive adolescent clients who remain in HIV and AIDS programs different from those who
drop out in terms of sociodemographic characteristics?
Understanding the extent to which adolescents aged 10–19 years who are living with HIV are retained
in HIV care, treatment, and support is important for informing the design of effective comprehensive
services for this subset of the population in order to better meet their needs across three main areas of
HIV and AIDS programming: treatment; care and support; and prevention. Effective, comprehensive
services that benefit adolescents and contribute towards their retention in HIV care, treatment, and
support programs are a pressing priority for the national AIDS control programs in many countries
affected by the epidemic. Retention in HIV programs is, in turn, important for positive clinical outcomes
including viral suppression and survival (Giordano 2012; Giordano et al. 2007; WHO 2012).
In 2013–2014, The AIDS Support Organization (TASO) and the Population Council undertook a
study to generate evidence on the level of and the factors associated with retention of adolescents aged
10–19 years in HIV and AIDS programs in Uganda. The study was conducted under the U.S. Agency
for International Development’s (USAID) HIVCore project led by the Population Council. The study
further responds to the guidelines by the World Health Organization (WHO) and the United Nations
Fund for Population Activities (UNFPA) on care, treatment, and support for women living with HIV and
AIDS and their children in resource-constrained settings that emphasize ensuring the availability of ageappropriate information and counseling on SRH and safer sexual practices, and offering family planning
counseling and services that are adolescent-friendly (WHO and UNFPA 2006).
The goal of the study was to generate evidence on the level of and the factors associated with retention of
HIV-positive adolescents aged 10–19 years in HIV and AIDS programs in Uganda. The specific objectives
of the study were to:
1. Examine the contextual factors that might facilitate or influence retention of adolescents in HIV care,
treatment, and support services in Uganda.
2. Examine the cascade of HIV care, treatment, and support services among adolescents aged 10–19 years
in Uganda and how these patterns compare with those of adults aged 20 years and above.
3. Examine the level of and trend in retention in care, treatment, and support programs among
adolescents aged 10–19 years in the country in the context of current HIV and AIDS programs at 6,
12, 24, 36, and 48 months following initiation of ART.
4. Assess the sociodemographic characteristics and clinical factors that are associated with retention in
HIV care, treatment, and support programs among adolescents in Uganda at three different follow-up
periods (12, 24, and 36 months).

Retention of Adolescents Living with HIV in Care, Treatment, and Support Programs in Uganda ■ 5

METHODOLOGY
Study Design and Sample

The study used existing national policy and program documents on HIV testing, counseling, treatment,
and support as well as retrospective secondary cohort clinical data from 11 clinics operated by TASO in
Uganda. The study population for the clinical component comprised:
1. 22,089 adolescents aged 10–19 years and 33,139 adults aged 20 years and above regardless of HIV
status who received HIV services under the home-based HIV testing and counseling (HBHTC)
program from 2005 (when TASO initiated the program) to 2011.
2. Clinical records of 617 HIV-positive adolescent clients aged 10–19 years (at the time of enrollment)
who received HIV care, treatment, and support services from TASO clinics between 2006 and 2011.
The steps in sample selection for each of the study populations are summarized in Figure 1.

Figure 1 Flow chart showing steps in sample selection
HBHTC DATASETS

HIV-NEGATIVE

HIV-POSITIVE

NOT ENROLLED
IN TASO

ENROLLED IN
TASO

NOT ELIGIBLE
FOR ART

ELIGIBLE FOR
ART

NOT STARTED
ON ART

STARTED ON
ART

ART DATASETS

PRE-ART
REGISTER
DEATH
REGISTER

CASE
EVALUATION
ART
COMMENCEMENT

LABORATORY

DRUG
REFILLS

MERGED ON UNIQUE PATIENT
IDENTIFICATION

SELECTION OF ADOLESCENTS
AGED 10–19 YEARS AT ENROLLMENT
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Review of Documents

The review of policy and program documents as well as the extraction and merging of clinical datasets
took place from 4–15 November 2013. The policy and program documents were obtained from TASO
and Uganda’s Ministry of Health. We undertook a review of the existing HIV and AIDS treatment, care,
and support program documents in Uganda (such as national policy guidelines on service provision
and training manuals for service providers) to determine the contextual factors that might facilitate or
influence enrollment into HIV care, initiation of treatment, and retention in treatment programs among
adolescents living with HIV. The results of the review are presented in the appendix.

Extraction of clinical datasets

The HBHTC and ART datasets were obtained from 11 TASO centers. The HBHTC datasets included
all individuals who were counseled and tested for HIV under the program regardless of whether they
were later enrolled in TASO programs. The ART datasets, on the other hand, comprised all individuals
who were enrolled in TASO programs regardless of where they were counseled and tested for HIV.
The ART datasets were extracted from the following records: Pre-ART Registry, Case Evaluation, ART
Commencement, Deaths, Monitoring Refills, and Laboratory (Figure 1). A cohort of adolescent clients
aged 10–19 years who were initiated on ART between January 2006 and December 2011 at TASO
clinics were included in the analysis. TASO collects information on date of testing, date of enrollment
in care and support programs, date of confirmation of eligibility for antiretroviral drugs (ARVs), date of
commencement of ARVs, and dates of drug refills since the client was started on ARVs. The ART datasets
for the various components of HIV care, treatment, and support including registration, determination of
eligibility for ART, and commencement and adherence to treatment from all the eleven centers are stored
in separate files in Access format at TASO headquarters and include all age groups. However, each file
contains unique client identifier numbers that were used to merge information pertaining to the same
client from the different datasets.

Data Analysis

Analysis involved both descriptive statistics and multivariate Cox regression analysis. Descriptive analysis
entailed reviewing the cascade of HIV care, treatment, and support services under the HBHTC program
as well as estimating the level of retention in TASO ART programs. The review of the cascade of care
was conducted for adolescents aged 10–19 years and adults aged 20 years and above. Analysis entailed
simple frequencies to determine the proportions of adolescents and adults that: (i) tested positive among
those who received HBHTC since 2005; (ii) were enrolled in care and support programs at TASO centers
among those who tested positive during HBHTC; (iii) were determined to be eligible for ART among
those who were enrolled in care and support programs at TASO centers; and (iv) were started on ART
among those who were determined to be eligible. The purpose of the analysis was to determine whether
the proportions of adolescents were significantly different from those of adults at each stage in the cascade.
Significance tests of proportions were conducted to determine whether the differences between the two
groups were statistically significant.
With respect to the level of retention, the percentage of patients with HIV known to be on treatment
6 and 12 months after initiation of ART and at yearly intervals thereafter (e.g., 24, 36, 48 months) is
recommended as a core indicator for documenting program retention over time (Tassie et al. 2010). It is
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generated per calendar year by selecting all patients starting ART during a given year (denominator) and
reporting those who are still alive and on ART at a specific time point (numerator)—that is, excluding
those who were known to have died, stopped ART, or were lost to follow-up (Tassie et al. 2010). We
calculated retention rate as the proportion of patients who were enrolled in TASO centers and alive
(including those who transferred to non-TASO centers) at the end of each observation period at 6, 12,
24, 36, and 48 months. We further examined whether the level of retention at each observation period
differed among adolescents initiating treatment in each successive year from 2006 to 2010, which could
give an indication of the changing programmatic contexts.
Multivariate analysis was conducted to determine the sociodemographic and clinical factors associated
with program attrition at 12, 24, and 36 months.1 The analysis involved estimation of three separate
Cox proportional hazard models for each of the time periods with exposure defined from the time of
enrollment in the ART program to the end of analysis period (i.e., at 12, 24, and 36 months). The
incidence rates of subcategories of attrition (dead, lost to follow-up [LTFU], and treatment stopped) were
expressed as the number of patients with at least one occurrence of the given event per 100 person years.
A two-tailed statistical test with a p-value of <0.05 was considered to be statistically significant. Baseline
characteristics included patient’s sociodemographics such as age (10–14 and 15–19 years), sex (male
and female), and religious affiliation (Anglican, Catholic, Muslim, and Protestant); available measures
of disease severity including CD4 count (<100 cells/µl, 100–249 cells/µl, and 250 or more cells/µl) and
WHO clinical staging (Stage 1&2 and Stage 3&4); adherence level (<75 percent, 75 percent–95 percent,
and greater than 95 percent); and mode of ART delivery (community drug distribution points [CDDP]
and health facility). Adherence level was determined by the frequency of taking drugs based on a threeday recall and pharmacy records within a given quarter. Patients were defined as LTFU if their last patient
contact was more than three months before the end date of the observation period and were considered
to have been lost to follow up at their last contact date. The results are presented as adjusted hazard ratios
(AHR) with 95 percent confidence intervals (CI).

Ethical Considerations

The study obtained ethical approval from the Population Council Institutional Review Board, TASO
Institutional Review Committee and the Uganda National Council for Science and Technology
(UNCST). In addition, no personal identifiers such as names, addresses, or contact information of clients
were included in the extracted clinical data. Rather, a unique patient identification number was used to
merge the datasets from the various records.

At 48 months, the model could not converge because of missing data.

1
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Key findings
CHARACTERISTICS OF ADOLESCENTS

Table 1 presents the distribution of adolescents who were enrolled in TASO programs during the period.
The majority of the adolescents were female (63 percent), reflecting the generally higher HIV prevalence
among women (8 percent) than men (6 percent) in the country (Ministry of Health et al. 2012).
More than half (55 percent) of the adolescents were aged 10–14 years while 75 percent had primary
level education. Most of the adolescents (73 percent) had CD4 counts of 100 and above at the time of
initiating ART, while 91 percent had adherence level above 95 percent. One-quarter (25 percent) of the
adolescents were sexually active (had ever had sex) suggesting that the majority were born with HIV. Most
of the adolescents (62 percent) obtained their drug refills from a health facility (Table 1).
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Table 1 Distribution of adolescents aged 10–19 years in TASO ART programs by
background characteristics at the time of enrollment, 2006–2011
Characteristics

Percent

Number of
adolescents

63.2
36.8

390
227

26.6
29.2
22.8
21.4

164
180
141
132

7.3
75.0
15.9
1.8

45
461
98
11

36.0
42.4
10.6

221
260
65

7.8
1.1
2.1

48
7
13

36.3
62.1
1.6

224
383
10

<100 cells/µl

27.0

154

100–249 cells/µl

37.0

211

36.0

205

71.5
28.5

436
174

24.6
75.4

143
139

Sex of client
Female
Male
Age (years)
10–11
12–14
15–17
18–19
Highest level of education completed
None/pre-primary
Primary
Senior 1–4
Senior 5 and above
Religion
Anglican
Catholic
Muslim
Pentecostal
Seventh Day Adventist
Other
Venue of ARV refill
CDDP
Health facility
Home/other
CD4 at ART initiation

250 or more cells/µl
WHO clinical staging
Stage 1 & 2
Stage 3 & 4
Sexually active (ever had sex)
Yes
No
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Cascade of Care under HBHTC PROGRAM

Between 2005 and 2011, TASO tested a total of 77,881 clients through the HBHTC program. Out of
these, 28 percent were adolescents aged 10–19 years and 43 percent were adults aged 20 years and above.
Table 2 presents the numbers of adolescents and adults that went through the cascade of the TASO
HBHTC program during the period.
Table 2 Number of adolescents 10–19 years and adults 20 years and above who
received various HIV services through the TASO HBHTC program, 2005–2011
Number
tested

Number
positive

Number
enrolled

Number
eligible for
ART

Number
initiated
on ART

Adolescents 10–19 years
2005
2006
2007
2008
2009
2010
2011
Total

675
4,447
3,833
2,966
4,318
5,076
774
22,089

33
126
73
64
68
79
18
461

3
40
29
26
21
16
5
140

1
6
7
9
6
6
2
37

1
5
5
9
6
5
2
33

Adults 20 years and above
2005
2006
2007
2008
2009
2010
2011
Total

732
5,214
5,336
3,782
7,570
9,079
1,426
33,139

104
557
656
529
794
920
178
3,738

22
179
213
161
127
203
29
934

6
29
76
57
38
61
10
277

6
28
72
52
34
57
8
257

Year

Overall, 8 percent of adolescents and adults tested through the program were HIV-positive (2 percent
of adolescents and 11 percent of adults; Figure 2). As expected the proportion of adolescents who tested
positive was consistently lower than that of adults across the years (p<0.01 in all cases). Over time, the
proportion of adolescents that tested positive under the program declined by more than half from 5
percent in 2005 to 2 percent in 2011. However, the proportion of adults aged 20 years and above that
tested positive under the program fluctuated between 10 percent and 14 percent (Figure 2).
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Figure 2 Percentage of adolescents 10–19 years and adults 20 years and above who
were HIV-positive among those tested through the TASO HBHTC program, 2005–2011
15

14.2

14.0

percentage

12.5

12.3

12

10.7

11.3

10.5

10.1

9
6

4.9
2.8

3
0

2005

2006

1.9
2007

2.2

2008
Adolescents

1.6

1.6

2009

2010

2.3

2011

2.1

All years

Adults

Under the HBHTC program, the proportion of HIV-positive adolescents that were enrolled in TASO
centers more than tripled from 9 percent in 2005 to 32 percent in 2006 and steadily increased to 40
percent and 41 percent in 2007 and 2008 respectively (Figure 3). Nonetheless, the proportion of HIVpositive adolescents that were enrolled in TASO programs declined to 31 percent and 20 percent in 2009
and 2010 respectively. By contrast, the proportion of HIV-positive adults that were enrolled in TASO
centers increased by 11 percentage points between 2005 and 2006 (from 21 percent to 32 percent) before
levelling off at 33 percent in 2007. In addition, the proportion of adults that were enrolled in TASO
programs declined to 30 percent and 16 percent in 2008 and 2009 respectively (Figure 3). It is also
worth noting that during the first year of the program, a higher proportion of HIV-positive adults than
adolescents were enrolled in TASO centers. However, in 2006, a similar proportion of HIV-positive adults
and adolescents were enrolled in TASO programs while between 2007 and 2009, a higher proportion of
HIV-positive adolescents compared to adults were enrolled in the centers.

12 ■ Retention of Adolescents Living with HIV in Care, Treatment, and Support Programs in Uganda

Figure 3 Percentage of adolescents 10–19 years and adults 20 years and above who
were enrolled in TASO centers among those who tested positive through the HBHTC
program, 2005–2011
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Figure 4 presents the distribution of adolescents 10–19 years and adults aged 20 years and above who
were eligible for ART among those who were enrolled in TASO programs between 2005 and 2011. With
the exception of a slight decline in 2009, the proportion of adolescents who were found to be eligible
for ART more than doubled from 15 percent in 2006 to 40 percent in 2011. Over the same period, the
proportion of adults aged 20 years who were found to be eligible for ART more than doubled between
2006 and 2007 (from 16 percent to 36 percent) but fluctuated between 30 percent and 35 percent
thereafter (Figure 4). Among those who were eligible for treatment between 2005 and 2011, 89 percent
of adolescents and 93 percent of adults were initiated on TASO ART programs.
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Figure 4 Percentage of adolescents 10–19 years and adults 20 years and above who
were eligible for ART among those enrolled in TASO centers through the HBHTC
program, 2005–2011
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Level of Retention of Adolescents in ART Programs

Out of the 617 HIV-positive adolescents included in the study, 78 percent were still in TASO programs
and 6 percent had died, while 15 percent were lost to follow up during the review period. As expected,
the level of retention of adolescents declined with longer duration of stay in TASO ART programs. The
overall level of retention of adolescents in the programs was 96 percent at 6 months, 90 percent at 12
months, 83 percent at 24 months, 76 percent at 36 months, and 71 percent at 48 months (Figure 5).
Figure 5 Overall level of retention of adolescents 10–19 years in TASO ART programs,
2006–2011
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48 months

TRENDS IN Retention of Adolescents in ART Programs

Figure 6 presents the level of retention of various cohorts of adolescents in TASO ART programs. There is
little variation in the level of retention between different cohorts at 6 months (ranges from 93 percent for
the 2010 cohort to 100 percent for the 2006 cohort). At 12 months, however, there were wide variations
in the level of retention especially between the 2010 cohort and the other cohorts (79 percent for the
2010 cohort and over 90 percent for the 2006, 2007, 2008, and 2009 cohorts). The gaps in the level
of retention between cohorts of adolescents further widen as the duration increases to 24, 36, and 48
months, with the level of retention of later cohorts of adolescents being lower than that of earlier cohorts
(Figure 6).
Figure 6 Trends in retention of various cohorts of adolescents 10–19 years in TASO ART
programs, 2006–2011
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Factors Associated with Non-retention of
Adolescents in ART Programs

The results of the multivariate analysis predicting non-retention of adolescents aged 10–19 years in
TASO ART programs at various time points are presented in Table 3. The risk of non-retention in ART
programs was significantly greater among adolescents who obtained their ARV refills from a health facility
than among those who obtained the refills from CDDP at all the time points considered (i.e., 12, 24, and
36 months). In particular, the risk of non-retention was greater by 2.58 times at 12 months (95% CI:
1.26, 5.29), 1.59 times at 24 months (95% CI: 1.23, 2.05), and 1.31 times at 36 months (95% CI: 1.05,
1.61; Table 2) among adolescents who obtained their ARV refills from a health facility compared to those
who obtained the refills from CDDP. It is also worth noting that the magnitude of the differences in the
risk of non-retention in care by mode of ARV delivery reduced with time.
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The results in Table 3 further show that at 24 and 36 months, the risk of non-retention in care was
significantly greater (by between 1.33 and 1.41 times) among adolescents with higher compared to those
with lower CD4 count at the time of ART initiation. There was, however, no significant difference in
the risk of non-retention in care by the level of CD4 count at 12 months (Table 3). By contrast, there
was significant difference in the risk of non-retention in care by WHO clinical staging at 12 months but
not at 24 and 36 months. At 12 months, the risk of non-retention in care was 2.21 times greater among
adolescents at stage 3 and 4 than among those at stage 1 and 2 at the time of initiating ART.
With respect to age, the risk of non-retention in care was significantly greater among older (15–19 years)
than among younger (10–14 years) adolescents during the first two years following ART initiation. The
risk of non-retention was 1.88 times greater at 12 months (95% CI: 1.01, 3.48) and 1.30 times greater
at 24 months (95% CI: 1.02, 1.66) among older compared to younger adolescents. However, by the
third year, there was no significant difference in the risk of non-retention between older and younger
adolescents. The results also show that with longer duration of observation, the risk of non-retention in
care was significantly lower among male than among female adolescents. The risk was lower by 0.68 times
at 24 months (95% CI: 0.52, 0.88) and by 0.79 times at 36 months (95% CI: 0.64, 0.98) among male
compared to female adolescents. There was, however, no significant difference in the risk of non-retention
in care by sex of the adolescent at 12 months.

16 ■ Retention of Adolescents Living with HIV in Care, Treatment, and Support Programs in Uganda

Table 3 Hazard ratios from multivariate analysis predicting non-retention of
adolescents aged 10–19 years in TASO ART programs at various time points, 2006–2011
Covariate
Sex of client (ref: Male)
Female
Age of client (ref: 10–14 years)
15–19 years

12 months
AHR (95% CI)

24 months
AHR (95% CI)

36 months
AHR (95% CI)

1.09
(0.59, 2.02)

0.68**
(0.52, 0.88)

0.79*
(0.64, 0.98)

1.88*
(1.01, 3.48)

1.30*
(1.02, 1.66)

1.21
(0.98, 1.49)

1.05
(0.53, 2.10)
0.63
(0.18, 2.20)
1.65
(0.69, 3.92)

1.15
(0.88, 1.52)
0.88
(0.55, 1.38)
1.14
(0.77, 1.70)

1.16
(0.92, 1.46)
0.92
(0.62, 1.33)
1.19
(0.85, 1.67)

2.58**
1.26, 5.29)

1.59**
(1.23, 2.05)

1.31*
(1.05, 1.61)

2.21*
(1.19, 4.09)

0.99
(0.75, 1.31)

0.94
(0.74, 1.18)

1.13
(0.58, 2.20)
0.48
(0.20, 1.13)

1.38*
(1.01, 1.90)
1.41*
(1.02, 1.96)

1.36*
(1.05, 1.77)
1.33*
(1.02, 1.75)

0.31
(0.05, 2.05)
0.38
(0.08, 1.68)
1,311.5863
528

2.09
(0.48, 9.03)
1.84
(0.45, 7.55)
1,311.5863
528

1.32
(0.46, 3.83)
1.20
(0.44, 3.27)
1,311.5863
528

Religion (ref: Anglican)
Catholic
Muslim
Protestant
Mode of ARV delivery (ref: CDDP)
Health facility
WHO clinical staging at ART
initiation (ref: Stage 1 & 2)
Stage 3 & 4
CD4 at ART initiation
(ref: <100 cells/µl)
100–249 cells/µl
≥250 cells/µl
Adherence level (ref: <75%; poor)
75%–95% (Fair)
>95% (Good)
Person-years of observation
Number of persons

Notes: Adherence level was determined by the frequency of taking drugs based on a three-day recall and pharmacy records
within a given quarter; ref: reference category; *p<0.05; **p<0.01.
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conclusions and
recommendations
Discussion

The key findings of the study are that: 1) the overall level of retention of adolescents in TASO programs
is comparable with those of adults in existing studies, although there were variations in the retention
of various cohorts of adolescents especially from 12 months onwards; 2) the risk of non-retention of
adolescents in TASO care programs was significantly greater among those who obtained their ARV refills
from a health facility than among those who obtained the refills from community drug distribution points
at all the time points considered (12, 24 and 36 months); the risk of non-retention was significantly
greater among adolescents at WHO clinical stage 3 and 4 than among those at stage 1 and 2 at the time
of initiating ART (at 12 months); 3) the risk of non-retention in TASO care was significantly greater
among older (15–19 years) than among younger (10–14 years) adolescents (at 12 and 24 months) as well
as among adolescents with higher than among those with lower CD4 count at the time of initiating ART
(at 24 and 36 months); 4) the risk of non-retention in care was significantly lower among male compared
to female adolescents with longer duration of observation (at 24 and 36 months); and 5) the proportion
of HIV-positive adolescents that were tested under the HBHTC program and who were enrolled in
TASO centers more than quadrupled between 2005 and 2008 before declining by about half between
2008 and 2010.
The HIV and AIDS policy environment in Uganda is favorable for implementing interventions including
testing, counseling, treatment, and support programs for various population groups. However, effective
implementation of programs has been hampered by inadequate and inconsistent messaging, limited
human and financial resources to meet the demand for services, and lack of efficient management of
funds and supplies, as well as weak linkage and referral systems (Ministry of Health 2011; Uganda AIDS
Commission, n.d.). In addition, HIV-positive adolescents aged 10–19 years face challenges associated
with adherence to treatment and program retention as they transition from pediatric to adult care (Foster
and Fidler 2010). There are, however, no clear policy or programmatic actions aimed at reducing the
potential drop-out from care among adolescents during the transition from pediatric to adult care that is
evident from the review of policy and program documents. There is therefore need for clear policies and
concrete programs that address retention of HIV-positive adolescents in ART programs as they transition
from pediatric to adult care in the country.
Long-term retention of clients in ART programs is considered a major challenge for HIV programs
in sub-Saharan Africa (Harries et al. 2010). Studies show that although retention of clients in ART
programs in the region is more than 90 percent at 6 months, it declines with time ranging between 80
and 90 percent at 12 months, 70 and 80 percent at 24 months, and 60 and 70 percent at 36 months
(Geng et al. 2011; Fox and Rosen 2010; Tayler-Smith et al. 2010). In Uganda, it was estimated that as of
2011, 84 percent of clients were still on ART after 12 months of initiation (Republic of Uganda 2012).
Although the programmatic challenges are likely to affect the level of retention of adolescents in ART
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programs, the findings of this study show that the overall retention of adolescents in TASO programs is
comparable with those of adults in existing studies (Geng et al. 2011; Fox and Rosen 2010; Ministry of
Health 2011; Republic of Uganda 2012; Tayler-Smith et al. 2010). However, there were variations in
the level of retention of various cohorts of adolescents especially from 12 months onwards. Specifically,
retention decreased at each time period among adolescents initiating ART in each successive year since
2006 and the gaps widened with longer duration of observation. Whereas this could be an indication
of the changing program context (such as availability of funding, expansion of clinics leading to clients
transferring from TASO to new clinics, and changing treatment guidelines over the period), the design
of the study did not allow for exploring the specific reasons for the variations in the levels of retention of
adolescents by the year of initiating ART. It is, however, worth noting that the high levels of retention of
adolescents in TASO treatment programs could be due to the intensive resources geared toward targeting
whole families with HIV testing, counseling, treatment, and support services. Thus, although resources
for targeting whole families may not always be available, the programs provide valuable lessons for
improving access to treatment services among HIV-positive adolescents.
The second important finding of this study is that the risk of non-retention of adolescents in TASO care
programs was significantly greater among those who obtained their ARV refills from a health facility than
among those who obtained the refills from community drug distribution points at all the time points
considered (12, 24, and 36 months). In addition, at 12 months, the risk of non-retention in care was
significantly greater among adolescents at WHO clinical stage 3 and 4 than among those at stage 1 and
2 at the time of initiating ART. The findings suggest that community-based ART distribution initiatives
and early diagnosis of HIV infection do improve the chances of retaining adolescents in ART programs.
Community-based initiatives have been found to increase the uptake of HIV services in sub-Saharan
Africa (Matovu and Makumbi 2007). Early initiation of ART has, on the other hand, been associated
with decreasing trends in AIDS-related mortality in the country (Ministry of Health 2011). Variations
in the risk of non-retention in the TASO treatment programs by venue of drug refills could be due to the
fact that most HIV-positive adolescents with high levels of adherence receive drugs from community drug
distribution points while the less adherent ones receive drugs from health facilities. Nonetheless, a crosstabulation of adherence level and venue of drug refill showed that there was no significant association
between the two attributes, suggesting that counseling and close monitoring might have improved
adherence among clients who received drug refills from facilities.
The third key finding of the study is that the risk of non-retention in TASO care was significantly
greater among older (15–19 years) than among younger (10–14 years) adolescents at 12 and 24 months.
In addition, at 24 and 36 months, the risk of non-retention in care was significantly greater among
adolescents with higher than among those with lower CD4 count at the time of initiating ART. The
higher risk of non-retention among older compared to younger adolescents could be due to challenges
associated with transitioning from pediatric to adult care, given that ages 15–19 years also mark transition
to adulthood. Differences in retention by CD4 count could be due to the fact that adolescents with
higher CD4 count at the time of initiating ART may presume that they are healthy and might therefore
not feel the need to continue with treatment.
Available evidence indicates that women have better health-seeking behavior than men and that those
who are living with HIV are likely to initiate treatment earlier than men (Braitstein et al. 2008). Contrary
to this expectation, the results of the study show that the risk of non-retention in care was significantly
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lower among male compared to female adolescents with longer duration of observation (at 24 and 36
months). However, given that the study was based on secondary data, it was not possible to explore
further the reasons for lower risk of non-retention in care among male compared to female adolescents.
With respect to HBHTC, the program contributed to increasing proportions of adolescents aged 10–19
years being enrolled in TASO care centers during the first four years of its operation. In particular, the
proportion of HIV-positive adolescents who were enrolled in TASO centers more than quadrupled
between 2005 and 2008. However, the proportion of adolescents enrolled in TASO care centers under
the program declined by about half between 2008 and 2010. The initial success of the program and
the subsequent decline in the proportions of adolescents being in enrolled in care could partly reflect
the interplay between a supportive policy environment and the challenges associated with program
implementation in the country including the availability of adequate resources (Ministry of Health 2011;
Uganda AIDS Commission, n.d.). The overall proportions of adolescents who were tested through the
program and enrolled in TASO care centers also remained low across the years. This could largely be
due to the fact that although clients accepted being counseled and tested at home by TASO, it was not a
pre-condition that they had to enroll in TASO care centers. Rather, they might have chosen to enroll for
services elsewhere, which was entirely within their rights.

Conclusion

Although the level of retention of adolescents aged 10–19 years in TASO care centers is comparable to
those of existing studies among adults, significant variations exist at various time points by cohort, age,
sex, mode of ART delivery, WHO clinical staging, and CD4 count at the time of initiating treatment.
However, the findings show that community drug distribution points do improve retention of adolescents
in HIV care and treatment programs. Nonetheless, given the potential for selection bias, more research
is needed to determine whether the approach should be used to specifically target those at high risk of
dropping out of care and treatment programs.

Recommendations

yy HIV care, treatment, and support programs in Uganda should strengthen such strategies as community
drug distribution points, which have the potential of improving retention of adolescents in care and
treatment, to specifically target those who are at high risk of dropping out.
yy Since the issue of retaining older adolescents in HIV care and treatment programs could partly be
associated with challenges with transition from pediatric to adult care, more research is needed to
determine whether setting up transition units to cater for those who receive services from health
facilities but are not comfortable with obtaining services from pediatric or adult clinics could improve
retention.
yy Further research involving collection of primary quantitative and qualitative data is needed to
determine why later cohorts of adolescents had lower levels of retention in care compared to earlier
cohorts and why male adolescents had significantly lower risk of non-retention in care compared to
their female counterparts.
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APPENDIX:
Document review
Policy Context
Infrastructure
The first AIDS case was diagnosed in Uganda in 1982 and by 1986, the disease had reached the level
of a generalized epidemic predominantly transmitted through heterosexual contact (Ministry of Health
and ORC Macro 2006; Serwadda et al. 1985). In response, the Ugandan government (the Government)
established the AIDS Control Programme in the Ministry of Health in 1986 to carry out epidemiological
surveillance of the epidemic; ensure safe supply of blood for transfusion; and provide information,
education, and communication (IEC) as well as patient care and counseling services (Uganda AIDS
Commission 2000). The Government adopted a multi-sectoral approach in dealing with the epidemic
in 1990/1991. The Uganda AIDS Commission was created in 1992 to coordinate the multi-sectoral
response encompassing HIV prevention, counseling, testing, care, and support services involving public,
private, civil society, and community-based organizations (Ministry of Health and ORC Macro 2006).

HIV prevention policy
In 1999, the Government issued the National Health Policy with one of its priorities being the prevention
and control of HIV. This was to be achieved through information, education, and communication (IEC)
campaigns; HIV counseling and testing; promotion of condom use; treatment of sexually transmitted
infections (STIs); reduction of mother-to-child transmission; provision of palliative care; and promotion
of community involvement in the care of patients with AIDS (Ministry of Health 1999). In 2000,
the Government unveiled the National Strategic Framework for AIDS Activities in the country for the
period 2001–2006 focusing on promotion of abstinence, faithfulness, and condom use (ABC); reducing
mother-to-child transmission of HIV as well as providing care and support to households affected by the
epidemic (Uganda AIDS Commission 2000). At the expiration of the National Strategic Framework, the
Government developed a new strategic plan in 2007, the National HIV&AIDS Strategic Plan 2007–2012,
which had goals to reduce the incidence of HIV and AIDS by 40 percent and to expand care, treatment,
and support interventions to 80 percent of those in need by the year 2012 (Uganda AIDS Commission
2007). In addition, the policies and strategic plans recognized the importance of addressing underlying
factors that constrain HIV prevention such as harmful sociocultural and gender norms, inequitable access
to services, gender-based violence, and stigma and discrimination (Ministry of Health 1999; Uganda
AIDS Commission 2000, 2007).

HIV testing and counseling policy
The Government issued the first Voluntary Counseling and Testing (VCT) Policy in 2002, which had the
goal of ensuring access to high-quality VCT services for all people in Uganda (Ministry of Health 2010a,
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2010b). The policy was revised in 2005 to HIV Counselling and Testing Policy in order to encompass new
models of testing including provider-initiated testing and counseling (PITC) and HBHTC (Ministry
of Health 2005, 2010a, 2010b). The policy was again revised in 2010 to take into account emerging
issues such as key populations, special groups including children and persons with disabilities, quality
assurance, safe medical circumcision, and ethical and legal issues around HIV counseling and testing
(Ministry of Health 2010a). The Government further issued the National Implementation Guidelines for
HIV Counselling and Testing in the country at the same time to guide the implementation of the HIV
Counselling and Testing Policy (Ministry of Health 2010b).

HIV treatment, care and support policy
With respect to treatment, care and support services, the Government developed the Antiretroviral
Treatment Policy for Uganda in 2003, with objectives to: (1) standardize the provision of ART and related
services to adults and children; (2) build capacity of healthcare workers to provide ART in a safe, effective,
and integrated manner; and (3) ensure uninterrupted supply of antiretroviral (ARV) drugs, laboratory
reagents, and medical supplies (Ministry of Health 2003a). The Government further issued the Policy for
Reduction of the Mother-to-Child HIV Transmission in Uganda in the same year. The objective of this policy
was to guide the provision of ART for prevention of mother-to-child transmission (PMTCT) of HIV
and reduce pediatric HIV cases (Ministry of Health 2003b). In 2009, the Government unveiled revised
ART guidelines for adults, adolescents, and children to take into account the 2006 revision of WHO
global ART recommendations (Ministry of Health 2009a; WHO 2006). Improving access to quality HIV
treatment and care services was also a key focus of the third Health Sector Strategic Plan for the period
2010–2015 and the National Strategic Plan for HIV&AIDS for the period 2011–2015 (Ministry of Health
2010c; Republic of Uganda 2011).
One of the Government’s policy goals is to mitigate the health and socio-economic effects of HIV and
AIDS on individuals, households, and communities in Uganda (Uganda AIDS Commission 2000).
Besides treatment, nutritional support is one strategy that the Government has outlined for mitigating
the health impact of the epidemic. To this end, the Government issued guidelines for service providers
on nutritional care and support for people living with HIV in the country (Republic of Uganda, n.d.).
In addition, the Health Sector Strategic Plan III for the period 2010–2015 emphasized incorporating
nutritional support into the management and treatment of HIV and AIDS (Ministry of Health 2010c).
Other care and support strategies that the Government has outlined in various policy documents include:
(1) promoting palliative care and social and spiritual support for children infected and affected by HIV
and AIDS; (2) providing psychosocial, financial, and material support (shelter, food, school fees) to AIDS
orphans, child-headed households, and guardians/foster families; (3) promoting home-based care for
people living with HIV; (4) developing income-generating projects with skills development components
and training family members in the management and monitoring of the projects; and (5) identifying
non-governmental organizations (NGOs) and micro-financing institutions to extend credit to the families
most affected by HIV and AIDS (Uganda AIDS Commission 2000, 2007; Ministry of Health 2003).
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Programmatic Context
IEC/BCC campaigns
The first AIDS control program was set up in Uganda in 1987 with an emphasis on the ABC approach
to HIV prevention (Genuis and Genuis 2005; Green et al. 2006; Ministry of Health and ORC Macro
2006). The approach involved IEC/behavior change communication (BCC) campaigns using various
channels including mass media (print materials, radio, and billboards), community mobilization, and
interpersonal communications (Green et al. 2006). The campaigns targeted the general population as
well as specific groups such as youth, female sex workers and their clients, traders, fishermen, soldiers,
long distance drivers, bar girls, police, and students (Green et al. 2006). The messages focused not only
on ABC but also cross-generational sex as well as modes of HIV transmission (Green et al. 2006). The
campaigns have been carried out throughout the country by the Government as well as faith-based, civil
society, and community-based organizations (Green et al. 2006; Okware et al. 2005).

HIV counseling and testing services
The ABC prevention strategy was later expanded to include HIV counseling and testing (HCT), PMTCT,
ART, and HIV care and support services—a strategy also known as ABC Plus (Ministry of Health and
ORC Macro 2006). The country employs various HCT models including routine HIV counseling
and testing for pregnant women (sentinel surveillance), VCT or client-initiated counseling and
testing (CICT), PITC, HBHTC, couples HIV counseling and testing (CHCT), mobile HIV testing,
and moonlight (night-time) testing for high-risk groups such as sex workers (Ministry of Health 2005;
Republic of Uganda 2011). The sentinel surveillance system was established in 1985 in Kampala before
being rolled out to other sites in 1989 (Garbus and Marseille 2003). Between 1989 and end of 2001,
the number of sentinel sites increased from six located in a few places in and outside Kampala to 20 sites
spread throughout the country but mostly in urban and peri-urban clinics (Garbus and Marseille 2003).
VCT was first launched in the country in 1990 with the establishment of the AIDS Information Center
(AIC) in Kampala and by 2002, AIC had 70 sites in 34 districts (Garbus and Marseille 2003; Menzies
et al. 2009; Ministry of Health 2010a). The Ministry of Health started a voluntary door-to-door HIV
counseling and testing program in 1999 (Menzies et al. 2009; Wanyeze et al. 2008). The Ministry further
launched the national couples HIV counseling and testing in the same year under the campaign ‘Go
Together, Know Together’ (Ministry of Health 2009b). In addition, the Government began rolling out
PITC in 2013 after initial piloting of the strategy in regional referral hospitals (Kajja 2013). Moonlight
HIV counseling and testing was, on the other hand, first piloted by AIC in Arua district in 2007 before
being rolled out to other districts (AIC 2013). Thus, HCT services have been expanded in all districts in
the country with the national guidelines allowing for provision of the services in health facilities (public,
private, faith-based, and NGO), community settings (e.g., stand-alone sites, home or workplace), and in
special circumstances such as surveillance or research settings (Ministry of Health 2010b). By 2011, HCT
services were available in all hospitals and Health Center Level IV, 80 percent of Health Center Level III,
and 22 percent of Health Center Level II facilities (Republic of Uganda 2012). Estimates from the 2011
Uganda AIDS Indicator Survey show that 60 percent of adults aged 15–49 years had ever been tested for
HIV (Ministry of Health et al. 2012).
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Treatment services
The Ministry of Health began offering free PMTCT services in 2000 (WHO et al. 2009). However, by
2005, the proportion of HIV-positive mothers receiving PMTCT services was only 12 percent (WHO
et al. 2009). By 2010, 1,150 health facilities were providing PMTCT services in the country including
all public and private hospitals and Health Center Level IV, 90 percent of Health Center Level III, and
10 percent Health Center Level II facilities (Republic of Uganda 2012). Over the same period, the
proportion of HIV-positive mothers receiving PMTCT services in the country increased to 53 percent
(WHO et al. 2010). Since the Government launched universal access to free antiretroviral drugs in 2004,
a total of 409 public and private facilities had been accredited to provide ART by the end of December
2008, and, of the 357,000 people estimated to need treatment, about 168,000 were already accessing
ART countrywide (Ministry of Health 2009). By 2011, it was estimated that 58 percent of adults and
children in need of ART were accessing the services (Republic of Uganda 2012).

Care and support services
With respect to care and support, efforts by the government, private sector, and civil society organizations
(CSOs) have focused on alleviating the impact of HIV and AIDS on people living with HIV, orphans
and vulnerable children (OVC), and affected households and communities (Republic of Uganda 2012). A
2009 evaluation of forms of care available at sampled health facilities in the country found that the most
common components were adherence counseling, nutritional advice, family planning counseling, preand post-HIV test counseling, treatment for diarrhea, and treatment for skin rash (Harding et al. 2009).
Other forms of care and support include psychosocial support services especially for OVC, including life
skills, counseling and guidance, formal education, and vocational training (Harding et al. 2009; Republic
of Uganda 2012). The universal primary and secondary education initiatives by the government have,
for instance, led to continued increase in the number of OVC in primary and secondary schools in the
country (Republic of Uganda 2012). In addition, some CSOs have interventions addressing household
food insecurity and malnutrition while the government’s Social Assistance Grants for Empowerment
(SAGE) program initiated in 2010 aims to provide social protection to poor households (Republic of
Uganda 2012).

Summary And Implications

In summary, the HIV and AIDS policy environment in Uganda is favorable for implementing
interventions including testing, counseling, treatment, and support programs for various population
groups. The policies have also been consistently updated in line with national and international
developments regarding the epidemic. For instance, the revised National Strategic Plan for HIV&AIDS
for the period 2011–2015 took into account the principles of combination prevention, which has been
defined as “rights-based, evidence-informed, and community-owned programmes that use a mix of
biomedical, behavioral, and structural interventions, prioritized to meet the current HIV prevention
needs of particular individuals and communities, so as to have the greatest sustained impact on reducing
new infections” (Republic of Uganda 2011; UNAIDS 2010b:8). In particular, the policies promote
evidence-based interventions such as HIV counseling and testing, PMTCT, safe medical circumcision,
ART, and condom use as well as behavioral and structural interventions including IEC/BCC, STI
treatment, and medical infection control (Republic of Uganda 2011). The policies further outline
measures for comprehensive social support protection for individuals, households, and communities to
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enable them to prevent, manage, and overcome risks and vulnerabilities associated with the epidemic. It
is, however, worth noting that some policies, such as the Anti-Homosexuality Act of 2014 (Ministry of
Justice 2014), remain unfavorable for programs that target key populations such as men who have sex
with men (Semugoma et al. 2012). There is also no clear policy that addresses retention of HIV-positive
adolescents on ART as they transition from pediatric to adult care.

In spite of the remarkable progress in HIV and AIDS programming in the country, challenges remain.
For example, there have been inconsistencies in the IEC messages about the effectiveness of the various
elements of the ABC strategy (A, B, and C) in changing behavior (Uganda AIDS Commission, n.d.).
In addition, the IEC/BCC messages have largely been based on mass media campaigns rather than
interpersonal communication (Uganda AIDS Commission, n.d.). There also has been limited emphasis
on prevention counseling for individuals who test HIV-negative in order to remain uninfected (Uganda
AIDS Commission, n.d.). Effective provision of HCT, PMTCT, and ART services is, on the other hand,
hampered by limited human and financial resources to meet the demand, lack of efficient management
of funds and supplies, and weak linkage and referral systems (Onyango and Magoni 2002; Republic
of Uganda 2012). Budget constraints have also limited the country’s ability to address the needs and
demands of people living with HIV, orphans, and affected households and communities (Republic of
Uganda 2012). HIV-positive adolescents also face challenges associated with adherence to treatment
and program retention as they transition from pediatric to adult care (Foster and Fidler 2010). These
challenges may negatively impact the level of retention of adolescents in care, treatment and support
programs in the country.
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